Titration Study to Evaluate Efficacy and Satisfaction of Viagra in Men With Erectile Function.
NCT ID: NCT00249730
Last Updated: 2021-02-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
510 participants
INTERVENTIONAL
2005-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality of Erection Study
NCT00159900
Effect of Sildenafil on Quality of Sexual Life in Mild to Normally Sexually Functioning Males
NCT00313898
Assessment Of Sildenafil On Erectile Function And Intercourse Satisfaction And To Validate A New Subject Questionnaire
NCT00147628
Impact Of Viagra On Sexual Satisfaction Of Men With Mild Erectile Dysfunction Who Are Sexually Dissatisfied
NCT00301262
A Study Of The Evaluation Of Patients Opulation With Erectile Dysfunction, Treated With Sildenafil
NCT01108900
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sildenafil
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects must be in a stable relationship with the same partner for at least 6 months and willing to attempt sexual intercourse.
Exclusion Criteria
* Subjects who are currently taking or are likely to be treated with nitrates or nitric oxide donors in any form (oral, sublingual, buccal, transdermal, inhalational or as aerosols) on either regular or intermittent basis.
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pfizer Investigational Site
Kitchener, Ontario, Canada
Pfizer Investigational Site
Sarnia, Ontario, Canada
Pfizer Investigational Site
Toronto, Ontario, Canada
Pfizer Investigational Site
Saint-Léonard, Quebec, Canada
Pfizer Investigational Site
Trois-Rivières, Quebec, Canada
Pfizer Investigational Site
Lille, , France
Pfizer Investigational Site
Lyon, , France
Pfizer Investigational Site
Montpellier, , France
Pfizer Investigational Site
Paris, , France
Pfizer Investigational Site
Goudi, Athens, Greece
Pfizer Investigational Site
Pátrai, , Greece
Pfizer Investigational Site
Thessaloniki, , Greece
Pfizer Investigational Site
Beersheba, , Israel
Pfizer Investigational Site
Haifa, , Israel
Pfizer Investigational Site
Petah Tikva, , Israel
Pfizer Investigational Site
Tel Aviv, , Israel
Pfizer Investigational Site
Bologna, , Italy
Pfizer Investigational Site
Florence, , Italy
Pfizer Investigational Site
L’Aquila, , Italy
Pfizer Investigational Site
Milan, , Italy
Pfizer Investigational Site
Roma, , Italy
Pfizer Investigational Site
Moscow, , Russia
Pfizer Investigational Site
San Cristóbal de La Laguna, Santa Cruz De Tenerife, Spain
Pfizer Investigational Site
Alicante, , Spain
Pfizer Investigational Site
Barcelona, , Spain
Pfizer Investigational Site
Madrid, , Spain
Pfizer Investigational Site
Málaga, , Spain
Pfizer Investigational Site
Seville, , Spain
Pfizer Investigational Site
Valencia, , Spain
Pfizer Investigational Site
Belmont, Durham, United Kingdom
Pfizer Investigational Site
Ashford, Middlesex, United Kingdom
Pfizer Investigational Site
Weybridge, Surrey, United Kingdom
Pfizer Investigational Site
Chippenham, Wilts., United Kingdom
Pfizer Investigational Site
Trowbridge, Wiltshire, United Kingdom
Pfizer Investigational Site
Bath, , United Kingdom
Pfizer Investigational Site
Coventry, , United Kingdom
Pfizer Investigational Site
Doncaster, , United Kingdom
Pfizer Investigational Site
Dundee, , United Kingdom
Pfizer Investigational Site
Glasgow, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A1481237
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.